NEW YORK, June 10, 2022 /PRNewswire/ -- As per the Zion Market Research study, The global peptide therapeutics market was valued at $35B in 2021 and is projected to grow at 11% CAGR during the forecast period & reach over $74B by 2028. The report analyzes the peptide therapeutics market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the global peptide therapeutics market.
Key Industry Insights & Findings of the Peptide Therapeutics Market Reports:
- As per the analysis shared by our research analyst, the Peptide Therapeutics Market is expected to grow annually at a CAGR of around 11 % (2022-2028).
- Through the primary research, it was established that the Cognitive and Memory Enhancer Drugs Market was valued at approximately USD 35 Billion in 2021 and is projected to reach roughly USD 74 Billion by 2028.
- North America region is the hub of key pharmaceutical players, high technology, R&D investment capacity, and world-class cancer treatment facilities, making it a heavily contributing region in the global market.
- Europe is expected to show steady growth in the global market because of its advanced healthcare infrastructure and growing awareness related to peptide therapeutics.
- Africa & Latin America are expected to grow slowly owing to a lack of information on peptide therapeutics along with an absence of necessary healthcare infrastructure, resources, and treatment facilities.
Zion Market Research published the latest report titled "Peptide Therapeutics Market By Route Of Administration (Parenteral, Oral, And Others), By Type (Innovative And Generic), By Type Of Manufacturers (In-House And Outsourced), By Type Of Molecule (Vasopressin, Somatostatin, Calcitonin, Immunopeptide, Natriuretic, And Others), By Technology (Liquid Phase, Solid Phase, And Hybrid Phase), By Application (Cancer, Cardiovascular Disease, Metabolic Disease, Respiratory Disease, Infectious Disease, And Others), And By Region: Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 - 2028" into their research database.
Peptide Therapeutics Market: Overview
Peptide therapeutics are naturally created disease-treating small chain amino acids known as peptides. They assist humans in hormone creation and are excellent at protecting from infections. Since peptide therapeutics are naturally created by the body, they do not have any side effects and are easily accepted by the body during medical treatments.
Peptide therapeutics are century-old but were only known for their healing abilities. However, with technological advancements and extensive R&D, it was discovered that peptide therapeutics have extreme potential in treating severe diseases with great efficiency.
The global peptide therapeutics market has a substantial presence in the field of acute respiratory disorders, endocrinology, oncology, metabolism disorders, diabetes, dermatology, gastroenterology, and sexual dysfunction. They are also used to treat cardiovascular diseases and bone diseases.
Get a Free Sample Report with All Related Graphs & Charts (with COVID 19 Impact Analysis):
https://www.zionmarketresearch.com/sample/peptide-therapeutics-market
Our Free Sample Report Includes:
- 2022 Updated Report Introduction, Overview, and In-depth industry analysis
- COVID-19 Pandemic Outbreak Impact Analysis Included
- 199 + Pages Research Report (Inclusion of Updated Research)
- Provide Chapter-wise guidance on Request
- 2022 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
- Includes an Updated List of tables & figures
- Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis
- Zion Market Research methodology
Industry Dynamics:
Peptide Therapeutics Market: Growth Drivers
- Increase in cancer patients and respiratory disorders to propel the global market growth.
The growing number of patients suffering from cancer and its after-effects is a leading global market driver. The most prevalent treatment for cancer involves chemotherapy and radiation which leave long-lasting impacts on the patients giving rise to requirements for substitutes like peptide therapeutics. This is expected to move the global peptide therapeutics market forward. Other chronic diseases like diabetes or cardiovascular diseases are also contributing to the global market growth.
Rising demand for drugs that have minimal to no side effects like peptide therapeutics is attributed to becoming the global market driver during the forecast period.
Exhaustive R&D on diseases that might raise global concerns and which can be treated by peptide therapeutics in the future is anticipated to drive the global market.
Peptide Therapeutics Market: Restraints
- Unstable nature of peptide therapeutics likely to hamper market growth.
Peptide therapeutics are extremely unstable rendering them difficult to be used. They can aggregate quickly resulting in damage to healthy cells. The volatility of peptide proteins is projected to act as a restraining factor for the global market growth.
In most cases, peptide therapeutics cannot be administered orally. The invasive techniques used for the intake of peptide-based drugs may cause reluctance amongst certain sections of the global population and are anticipated to restrain the global market during the forecast period.
Peptide therapeutics lack deep membrane permeability thus reducing the overall efficiency of the products, which is further anticipated to restrict the global market growth.
Peptide therapeutics tend to oxidize under improper care. The easy oxidization of peptide proteins increases task tediousness and is expected to hamper the global market.
Directly Purchase a Copy of the Report at https://www.zionmarketresearch.com/buynow/su/peptide-therapeutics-market
Global Peptide Therapeutics Market: Opportunities
- Advent of multi-functional peptide therapeutics to bring growth prospects in the coming period.
The global peptide therapeutics market has immense opportunities given the innumerable benefits of peptide-based drugs. The creation of multi-functional peptide therapeutics with an even wider array of use is anticipated to provide excellent growth opportunities in the global market.
Increased innovation in alternate delivery modes of peptide therapeutics is expected to open multiple opportunities for the global market during the forecast period.
Even though the presence of peptide therapeutics in the human body has been for more than a century, their discovery is a recent event. With every passing day more & more peptide therapeutics are added to the global market. As of 2022, there are more than 200 peptide therapeutics in the global market and with ongoing R&D, more are expected to be added soon.
This is anticipated to open multiple growth opportunities in the global market.
Global Peptide Therapeutics Market: Challenges
- Shift towards proteomics, high cost of peptide therapeutics along with quick expiration of patents to challenge the global market growth.
The global market is expected to move toward the study of proteins also called proteomics to create substitutes for peptide-based drugs which is anticipated to challenge the global market growth during the forecast period.
The development of peptide therapeutics is an expensive affair and the high cost of production & maintenance is anticipated to create challenging situations in the global market.
The creation of novel drugs requires approval from regulatory bodies and the approval process is extremely stringent which is anticipated to become a challenging factor in the global market.
A considerable number of patents for peptide therapeutics expire quickly which results in heavy losses to drug manufacturers and is anticipated to oppose the global market growth during the forecast period.
Global Peptide Therapeutics Market: Segmentation
- The global peptide therapeutics market is segmented by route of administration, type, type of manufacturers, type of molecule, technology, application, and region
Based on the route of administration, the global market is segmented into parenteral, oral, and others. Currently, the global market is led by the parenteral mode, however, the global market is anticipated to be led by the oral mode of administration, during the forecast period.
Based on the type of manufacturers, the global market is segmented as in-house and outsourced. In-house manufacturing shares the highest market share and the same trend is anticipated during the forecast period, because of stringent rules laid down by regulatory bodies.
Based on the type of molecule, the global market is segmented as vasopressin, somatostatin, calcitonin, immunopeptide, natriuretic, and others. Immunopeptide is projected to lead the global market share because of its effective use in the treatment of tumors and cancer.
Based on technology, the global market is segmented into liquid phase, solid phase, and hybrid phase. The largest global market share was held by the liquid phase and is expected to continue with the same trend during the forecast period.
Based on the application, the global market share was shadowed by cancer treatment previously. Since 2020, the global market share was dominated Covid-19 related treatments. However, cancer is anticipated to become the lead contributor during the forecast period.
Get More Insight before Buying at: https://www.zionmarketresearch.com/inquiry/peptide-therapeutics-market
List of Key Players in Peptide Therapeutics Market:
- Teva Pharmaceutical Industries
- AstraZeneca
- Sanofi S.A
- Amazen Inc.
- Takeda Pharmaceutical
- Ipsen S.A
- Merck & Co.
- Novo Nordisk A/S
- GlaxoSmithKline plc
- Ever Neuro Pharma
- Eli Lilly and Company
- CordenPharma International
Key questions answered in this report:
- What are the growth rate forecast and market size for Peptide Therapeutics Market?
- What are the key driving factors propelling the Peptide Therapeutics Market forward?
- What are the most important companies in the Peptide Therapeutics Market Industry?
- What segments does the Peptide Therapeutics Market cover?
- How can I receive a free copy of the Peptide Therapeutics Market sample report and company profiles?
Report Scope:
Report Attribute | Details |
Market size value in 2021 | USD 35 Billion |
Revenue forecast in 2028 | USD 74 Billion |
Growth Rate | CAGR of almost 11 % 2022-2028 |
Base Year | 2020 |
Historic Years | 2016 - 2021 |
Forecast Years | 2022 - 2028 |
Segments Covered | By Product Type, By Application, and By End Use |
Forecast Units | Value (USD Billion), and Volume (Units) |
Quantitative Units | Revenue in USD million/billion and CAGR from 2022 to 2028 |
Regions Covered | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World |
Countries Covered | U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others |
Companies Covered | Teva Pharmaceutical Industries, AstraZeneca, Sanofi S.A, Amazen Inc., Takeda Pharmaceutical, Ipsen S.A, Merck & Co., Novo Nordisk A/S, GlaxoSmithKline plc, Ever Neuro Pharma, Eli Lilly and Company, CordenPharma International. |
Report Coverage | Market growth drivers, restraints, opportunities, Porter's five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis. |
Customization Scope | Avail customized purchase options to meet your exact research needs. https://www.zionmarketresearch.com/custom/3439 |
Free Brochure: https://www.zionmarketresearch.com/requestbrochure/peptide-therapeutics-market
Recent Developments:
- August 2019 witnessed the merger of Neoleukin Inc. and Aquinox Pharmaceuticals to invest in peptide therapeutics which are designed computationally. The firms intend to produce peptide-based drugs for diseases that currently do not have peptide therapeutics available for treatment.
- In June 2019, a collaboration between Gubra and Boehringer Ingelheim International was announced. The collaboration is intended to pave a way for newer peptide therapeutics drugs that will help in treating diabetes.
Regional Dominance:
- North America to lead the global market during the forthcoming period.
The global peptide therapeutics market is anticipated to be led by North America. This region is the hub of key pharmaceutical players, high technology, R&D investment capacity, and world-class cancer treatment facilities, making it a heavily contributing region in the global market.
Europe is expected to show steady growth in the global market because of its advanced healthcare infrastructure and growing awareness related to peptide therapeutics.
Asia-Pacific & the Middle East witnessed a rise in the global market because of Covid-19. Rising cancer, diabetes, and acute respiratory disorders along with increased healthcare investments are anticipated to assist the global market growth.
Africa & Latin America are expected to grow slowly owing to a lack of information on peptide therapeutics along with an absence of necessary healthcare infrastructure, resources, and treatment facilities.
Global Peptide Therapeutics Market is segmented as follows:
Peptide Therapeutics Market: By Route of Administration Outlook (2022-2028)
- Parenteral
- Oral
- Others
Peptide Therapeutics Market: By Type Outlook (2022-2028)
- Innovative
- Generic
Peptide Therapeutics Market: By Type of Manufacturers Outlook (2022-2028)
- In-house
- Outsourced
Peptide Therapeutics Market: By Type of Molecule Outlook (2022-2028)
- Vasopressin
- Somatostatin
- Calcitonin
- Immunopeptide
- Natriuretic
- Others
Peptide Therapeutics Market: By Technology Outlook (2022-2028)
- Liquid phase
- Solid-phase
- Hybrid phase
Peptide Therapeutics Market: By Application Outlook (2022-2028)
- Cancer
- Cardiovascular Disease
- Metabolic Disease
- Respiratory Disease
- Infectious Disease
- Others
Peptide Therapeutics Market: By Region Outlook (2022-2028)
North America
- The U.S.
- Canada
Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Browse Other Related Research Reports from Zion Market Research
- Genomics Personalized Health Market - Global Industry Analysis: The global Genomics Personalized Health market accounted for USD 4,789.2 Million in 2020 and is expected to reach USD 6,649.2 Million by 2028, growing at a CAGR of 4.4% from 2021 to 2028.
- Medical Supply Delivery Service Market - Global Industry Analysis: The global Medical Supply Delivery Service Market accrued earnings worth approximately 49.1 (USD Billion) in 2020 and is predicted to gain revenue of about 104.2 (USD Billion) by 2028, is set to record a CAGR of nearly 10.2% over the period from 2021 to 2028.
- Healthcare Video Conferencing Solutions Market - Global Industry Analysis: The global Healthcare Video Conferencing Solutions Market accrued earnings worth approximately 76.1 (USD Million) in 2020 and is predicted to gain revenue of about 115.2 (USD Million) by 2028, is set to record a CAGR of nearly 4.8% over the period from 2021 to 2028.
Browse through Zion Market Research's coverage of the Global Healthcare Industry
Follow Us on: LinkedIn | Twitter | Facebook
About Us
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us-after all-if you do well, a little of the light shines on us.
Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com/
Blog - https://zmrblog.com/
Logo: https://mma.prnewswire.com/media/1605489/Zion_Market_Research_Logo.jpg
